Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.
Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients
- Post author:
- Post published:March 25, 2024
- Post category:uncategorized